Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Optics Letters
|
October 16, 2009
Two-color light-emitting-diode source for high-precision phase-shifting interferometry
L Deck, F Demarest
Antimicrobial Agents and Chemotherapy
|
December 17, 2008
Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism
James F Demarest, Heather Amrine-Madsen, David M Irlbeck, et al.
Antiviral Research
|
October 2, 2025
Small molecule direct-acting antivirals for treatment of mpox
E Randall Lanier, Richard L Mackman, Lee Ruggiero, et al.
Antimicrobial Agents and Chemotherapy
|
December 17, 2008
Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope
Kathryn M Kitrinos, Heather Amrine-Madsen, David M Irlbeck, et al.
AIDS (London, England)
|
July 11, 2008
Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals
David M Irlbeck, Heather Amrine-Madsen, Kathryn M Kitrinos, et al.
European Journal of Immunology
|
January 1, 1995
Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission
G Pantaleo, J F Demarest, M Vaccarezza, et al.
European Journal of Immunology
|
September 1, 1994
Expression of a wide T cell receptor V beta repertoire in human T lymphocytes derived in vitro from embryonic liver cell precursors
A Poggi, J F Demarest, P Costa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 15, 1993
Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection
C Graziosi, G Pantaleo, L Butini, et al.
Antiviral Research
|
September 22, 2021
An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral
Justin G Julander, James F Demarest, Ray Taylor, et al.
AIDS (London, England)
|
November 1, 1993
HIV-1 infection in the lymphoid organs
C Graziosi, G Pantaleo, J F Demarest, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Optics Letters
|
October 16, 2009
Two-color light-emitting-diode source for high-precision phase-shifting interferometry
L Deck, F Demarest
Antimicrobial Agents and Chemotherapy
|
December 17, 2008
Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism
James F Demarest, Heather Amrine-Madsen, David M Irlbeck, et al.
Antiviral Research
|
October 2, 2025
Small molecule direct-acting antivirals for treatment of mpox
E Randall Lanier, Richard L Mackman, Lee Ruggiero, et al.
Antimicrobial Agents and Chemotherapy
|
December 17, 2008
Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope
Kathryn M Kitrinos, Heather Amrine-Madsen, David M Irlbeck, et al.
AIDS (London, England)
|
July 11, 2008
Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals
David M Irlbeck, Heather Amrine-Madsen, Kathryn M Kitrinos, et al.
European Journal of Immunology
|
January 1, 1995
Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission
G Pantaleo, J F Demarest, M Vaccarezza, et al.
European Journal of Immunology
|
September 1, 1994
Expression of a wide T cell receptor V beta repertoire in human T lymphocytes derived in vitro from embryonic liver cell precursors
A Poggi, J F Demarest, P Costa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 15, 1993
Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection
C Graziosi, G Pantaleo, L Butini, et al.
Antiviral Research
|
September 22, 2021
An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral
Justin G Julander, James F Demarest, Ray Taylor, et al.
AIDS (London, England)
|
November 1, 1993
HIV-1 infection in the lymphoid organs
C Graziosi, G Pantaleo, J F Demarest, et al.
Page
of 4